Back to results
CompletedPhase 2Phase 3

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease

NCT03486938

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Banner Alzheimer's Institute

Phoenix, Arizona, United States

+23 additional locations

View on ClinicalTrials.gov
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease — TrialFind